Literature DB >> 903677

Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus.

R M Welsh, P W Lampert, M B Oldstone.   

Abstract

Defective-interfering (DI) lymphocytic choriomeningitis virus (LCMV) prevented disease in the central nervous system produced by standard LCMV. Standard LCMV injected into Lewis rats two days after birth produced a disorder distinguishable clinically by weight loss and ataxia and histologically by infiltration of mononuclear cells and necrosis of the cerebellum. Concurrent injection of DI LCMV with standard LCMV prevented the disease and markedly reduced the synthesis of standard LCMV and of viral antigens in the brain. Because inhibition of viral synthesis occurred early (day 3) after infection and because no interferon activity could be demonstrated, it was concluded that the interference effect was likely due to DI virus-mediated homologous interference. Other experiments showed that DI LCMV blocked viral antigen synthesis in culture. The curtailed production of viral antigens and cytolytic standard virus by DI virus may play a role in control of acute and persistent viral infections.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 903677     DOI: 10.1093/infdis/136.3.391

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  A novel type of defective viral genome suggests a unique strategy to establish and maintain persistent lymphocytic choriomeningitis virus infections.

Authors:  B J Meyer; P J Southern
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

Review 2.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

3.  Molecular analysis of viral RNAs in mice persistently infected with lymphocytic choriomeningitis virus.

Authors:  S J Francis; P J Southern
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

4.  Sequence heterogeneity in the termini of lymphocytic choriomeningitis virus genomic and antigenomic RNAs.

Authors:  B J Meyer; P J Southern
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 5.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

6.  Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.

Authors:  P N Fultz; J A Shadduck; C Y Kang; J W Streilein
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

7.  Suppression of vesicular stomatitis virus defective intefering particle generation by a function(s) associated with human chromosome 16.

Authors:  C Y Kang; L G Weide; J A Tischfield
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

8.  Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity.

Authors:  Dongsheng Li; Min-Hsuan Lin; Daniel J Rawle; Hongping Jin; Zhonglan Wu; Lu Wang; Mary Lor; Mazhar Hussain; John Aaskov; David Harrich
Journal:  Commun Biol       Date:  2021-05-11

Review 9.  Lymphocytic choriomeningitis virus in southern France: four case reports and a review of the literature.

Authors:  M C Rousseau; M F Saron; P Brouqui; A Bourgeade
Journal:  Eur J Epidemiol       Date:  1997-10       Impact factor: 12.434

10.  Viral Strain Determines Disease Symptoms, Pathology, and Immune Response in Neonatal Rats with Lymphocytic Choriomeningitis Virus Infection.

Authors:  Jeffrey M Plume; Dylan Todd; Daniel J Bonthius
Journal:  Viruses       Date:  2019-06-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.